2022 Q3 Form 10-Q Financial Statement

#000110465922117563 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q3
Revenue $0.00
YoY Change
Cost Of Revenue $1.830M
YoY Change 771.43%
Gross Profit -$960.0K
YoY Change 1100.0%
Gross Profit Margin
Selling, General & Admin $1.850M
YoY Change 44.53%
% of Gross Profit
Research & Development $1.070M
YoY Change 87.72%
% of Gross Profit
Depreciation & Amortization $90.00K
YoY Change -78.05%
% of Gross Profit
Operating Expenses $749.9K
YoY Change 93.8%
Operating Profit -$749.9K
YoY Change 93.8%
Interest Expense $823.0K
YoY Change 4419.49%
% of Operating Profit
Other Income/Expense, Net $1.351M
YoY Change -93.36%
Pretax Income $601.3K
YoY Change -96.99%
Income Tax $162.3K
% Of Pretax Income 26.99%
Net Earnings $439.0K
YoY Change -97.8%
Net Earnings / Revenue
Basic Earnings Per Share -$0.71
Diluted Earnings Per Share $37.88K
COMMON SHARES
Basic Shares Outstanding 5.538M
Diluted Shares Outstanding 5.538M

Balance Sheet

Concept 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $384.5K
YoY Change -44.55%
Cash & Equivalents $384.5K
Short-Term Investments
Other Short-Term Assets $115.1K
YoY Change -34.16%
Inventory $1.110M
Prepaid Expenses $99.69K
Receivables $740.0K
Other Receivables $0.00
Total Short-Term Assets $499.6K
YoY Change -42.46%
LONG-TERM ASSETS
Property, Plant & Equipment $4.560M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $33.03M
YoY Change -90.12%
Other Assets $30.00K
YoY Change
Total Long-Term Assets $33.03M
YoY Change -90.12%
TOTAL ASSETS
Total Short-Term Assets $499.6K
Total Long-Term Assets $33.03M
Total Assets $33.53M
YoY Change -90.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.640M
YoY Change
Accrued Expenses $0.00
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.919M
YoY Change 45.74%
LONG-TERM LIABILITIES
Long-Term Debt $600.0K
YoY Change
Other Long-Term Liabilities $13.81M
YoY Change -48.88%
Total Long-Term Liabilities $14.41M
YoY Change -46.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.919M
Total Long-Term Liabilities $14.41M
Total Liabilities $19.33M
YoY Change -36.4%
SHAREHOLDERS EQUITY
Retained Earnings -$18.69M
YoY Change -36.29%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.20M
YoY Change
Total Liabilities & Shareholders Equity $33.53M
YoY Change -90.0%

Cashflow Statement

Concept 2022 Q3
OPERATING ACTIVITIES
Net Income $439.0K
YoY Change -97.8%
Depreciation, Depletion And Amortization $90.00K
YoY Change -78.05%
Cash From Operating Activities -$535.8K
YoY Change -30.82%
INVESTING ACTIVITIES
Capital Expenditures $90.00K
YoY Change -71.87%
Acquisitions
YoY Change
Other Investing Activities $303.0M
YoY Change
Cash From Investing Activities $303.0M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -302.3M
YoY Change
NET CHANGE
Cash From Operating Activities -535.8K
Cash From Investing Activities 303.0M
Cash From Financing Activities -302.3M
Net Change In Cash 170.9K
YoY Change -122.06%
FREE CASH FLOW
Cash From Operating Activities -$535.8K
Capital Expenditures $90.00K
Free Cash Flow -$625.8K
YoY Change -42.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Central Index Key
EntityCentralIndexKey
0001814215
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
twnd Threshold Trading Days For Redeem Public Shares After Completion Of Initial Business Combination
ThresholdTradingDaysForRedeemPublicSharesAfterCompletionOfInitialBusinessCombination
P10D
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39489
dei Entity Registrant Name
EntityRegistrantName
TAILWIND ACQUISITION CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1288435
dei Entity Address Address Line1
EntityAddressAddressLine1
1545 Courtney Ave
dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90046
dei City Area Code
CityAreaCode
646
dei Local Phone Number
LocalPhoneNumber
432-0610
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
384522
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
479694
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
99687
CY2022Q3 twnd Prepaid Taxes Current
PrepaidTaxesCurrent
15400
CY2021Q4 twnd Prepaid Taxes Current
PrepaidTaxesCurrent
111667
CY2022Q3 us-gaap Assets Current
AssetsCurrent
499609
CY2021Q4 us-gaap Assets Current
AssetsCurrent
591361
CY2022Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
33034062
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
334441194
CY2022Q3 us-gaap Assets
Assets
33533671
CY2021Q4 us-gaap Assets
Assets
335032555
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4639823
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3867106
CY2021Q4 twnd Accrued Offering Costs
AccruedOfferingCosts
109000
CY2022Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
279345
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4919168
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3976106
CY2022Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
600000
CY2022Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
2112863
CY2021Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
13733608
CY2022Q3 twnd Deferred Underwriting Fees Noncurrent
DeferredUnderwritingFeesNoncurrent
11697550
CY2021Q4 twnd Deferred Underwriting Fees Noncurrent
DeferredUnderwritingFeesNoncurrent
11697550
CY2022Q3 us-gaap Liabilities
Liabilities
19329581
CY2021Q4 us-gaap Liabilities
Liabilities
29407264
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18689431
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28591245
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-28590409
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33533671
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
335032555
CY2022Q3 twnd Formation And Operating Costs
FormationAndOperatingCosts
749880
CY2021Q3 twnd Formation And Operating Costs
FormationAndOperatingCosts
386940
twnd Formation And Operating Costs
FormationAndOperatingCosts
1462117
twnd Formation And Operating Costs
FormationAndOperatingCosts
4694296
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-749880
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-386940
us-gaap Operating Income Loss
OperatingIncomeLoss
-1462117
us-gaap Operating Income Loss
OperatingIncomeLoss
-4694296
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
822997
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
18214
us-gaap Investment Income Interest
InvestmentIncomeInterest
1573401
us-gaap Investment Income Interest
InvestmentIncomeInterest
82072
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-528216
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-20336305
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-11620745
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-21656844
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1351213
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20354519
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13194146
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
21738916
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
601333
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19967579
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11732029
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17044620
twnd Proceeds From Cash Withdrawn From Trust Account In Connection With Redemption
ProceedsFromCashWithdrawnFromTrustAccountInConnectionWithRedemption
302873885
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
162329
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
279345
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
439004
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
19967579
us-gaap Net Income Loss
NetIncomeLoss
11452684
us-gaap Net Income Loss
NetIncomeLoss
17044620
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-28590409
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
9161468
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-19428941
CY2022Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
440203
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
1852212
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-18016932
CY2022Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1110667
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
439004
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-46379897
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
7282560
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-39097337
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-10205519
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-49302856
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
19967579
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-29335277
us-gaap Profit Loss
ProfitLoss
11452684
us-gaap Profit Loss
ProfitLoss
17044620
us-gaap Investment Income Interest
InvestmentIncomeInterest
1573401
us-gaap Investment Income Interest
InvestmentIncomeInterest
82072
twnd Changes In Fair Value Adjustment Of Warrants
ChangesInFairValueAdjustmentOfWarrants
-11620745
twnd Changes In Fair Value Adjustment Of Warrants
ChangesInFairValueAdjustmentOfWarrants
-21656844
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-11980
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-100860
twnd Increase Decrease Prepaid Taxe
IncreaseDecreasePrepaidTaxe
15400
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
663717
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3058075
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
279345
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-801820
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1535361
twnd Cash Invested In Trust Account
CashInvestedInTrustAccount
600000
twnd Proceeds From Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes
ProceedsFromCashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes
706648
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
302980533
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
600000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
302873885
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
17000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-302273885
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-95172
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1552361
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
479694
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2245798
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
384522
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
693437
twnd Condition For Future Business Combination Number Of Businesses Minimum
ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum
1
CY2022Q3 twnd Number Of Subsidiaries
NumberOfSubsidiaries
1
CY2022Q3 twnd Transaction Costs
TransactionCosts
18847894
twnd Cash Underwriting Commissions
CashUnderwritingCommissions
6684314
CY2022Q3 twnd Deferred Underwriting Commissions
DeferredUnderwritingCommissions
11697550
twnd Stock Offering Other Offering Costs
StockOfferingOtherOfferingCosts
466030
twnd Condition For Future Business Combination Number Of Businesses Minimum
ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum
1
twnd Percentage Of Aggregate Fair Market Value Of Asset
PercentageOfAggregateFairMarketValueOfAsset
0.80
twnd Business Acquisition Percentage Of Voting Interests To Be Acquired On Post Transaction Entity Minimum
BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum
0.50
twnd Per Share Value Of Residual Assets Remaining Available For Distribution Which Is Held In Trust Account
PerShareValueOfResidualAssetsRemainingAvailableForDistributionWhichIsHeldInTrustAccount
10.00
twnd Minimum Net Tangible Assets Upon Consummation Of Business Combination
MinimumNetTangibleAssetsUponConsummationOfBusinessCombination
5000001
twnd Redemption Of Percentage Of Common Stock Included In Units Sold In Offering
RedemptionOfPercentageOfCommonStockIncludedInUnitsSoldInOffering
0.15
twnd Obligation To Redeem Percentage Of Common Stock With Respect To Any Other Material Provision Relating To Stockholders Rights Or Pre Initial Business Combination Activity
ObligationToRedeemPercentageOfCommonStockWithRespectToAnyOtherMaterialProvisionRelatingToStockholdersRightsOrPreInitialBusinessCombinationActivity
1
CY2022Q3 twnd Amount Of Loan To Be Contributed By Lender
AmountOfLoanToBeContributedByLender
600000
CY2022Q3 twnd Maximum Borrowing Capacity Related Party Debt
MaximumBorrowingCapacityRelatedPartyDebt
150000
CY2022Q3 twnd Additional Loan To Be Contributed By Lender Number Of Equal Installments
AdditionalLoanToBeContributedByLenderNumberOfEqualInstallments
2
twnd Number Of Time Termination Date Can Be Extended
NumberOfTimeTerminationDateCanBeExtended
2
twnd Extension Period For Termination Date
ExtensionPeriodForTerminationDate
P1M
twnd Number Of Time Termination Date Can Be Extended
NumberOfTimeTerminationDateCanBeExtended
2
twnd Extension Period For Termination Date
ExtensionPeriodForTerminationDate
P1M
twnd Extension Of Termination Date Advance Notice Period Prior To Applicable Deadlines
ExtensionOfTerminationDateAdvanceNoticePeriodPriorToApplicableDeadlines
P5D
twnd Extension Of Termination Date Maximum Advance Notice Period After Original Termination Date
ExtensionOfTerminationDateMaximumAdvanceNoticePeriodAfterOriginalTerminationDate
P6M
twnd Interest To Pay Dissolution Expenses
InterestToPayDissolutionExpenses
100000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
384522
CY2022Q3 twnd Working Capital Deficit
WorkingCapitalDeficit
4278182
CY2022Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
600000
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
18847894
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
twnd Transaction Costs Included In Accretion For Class Common Stock Subject To Redemption Amount
TransactionCostsIncludedInAccretionForClassCommonStockSubjectToRedemptionAmount
18132174
twnd Transaction Costs Expensed
TransactionCostsExpensed
715720
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2699
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0238
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
twnd Number Of Dilutive Securities
NumberOfDilutiveSecurities
0
CY2021Q3 twnd Number Of Dilutive Securities
NumberOfDilutiveSecurities
0
twnd Number Of Dilutive Securities
NumberOfDilutiveSecurities
0
CY2022Q3 twnd Number Of Dilutive Securities
NumberOfDilutiveSecurities
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p>
CY2022Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
600000
twnd Maximum Number Of Demands For Registration Of Securities
MaximumNumberOfDemandsForRegistrationOfSecurities
3
CY2022Q3 twnd Deferred Underwriting Commissions
DeferredUnderwritingCommissions
11697550
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
1
CY2022Q3 twnd Marketable Securities Held In Trust Account
MarketableSecuritiesHeldInTrustAccount
33034062
CY2021Q4 twnd Marketable Securities Held In Trust Account
MarketableSecuritiesHeldInTrustAccount
2040
CY2021Q4 twnd Cash Held In Trust Account
CashHeldInTrustAccount
334439154
twnd Proceeds From Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes
ProceedsFromCashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes
706648

Files In Submission

Name View Source Status
0001104659-22-117563-index-headers.html Edgar Link pending
0001104659-22-117563-index.html Edgar Link pending
0001104659-22-117563.txt Edgar Link pending
0001104659-22-117563-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
twnd-20220930.xsd Edgar Link pending
twnd-20220930x10q.htm Edgar Link pending
twnd-20220930xex31d1.htm Edgar Link pending
twnd-20220930xex31d2.htm Edgar Link pending
twnd-20220930xex32d1.htm Edgar Link pending
twnd-20220930xex32d2.htm Edgar Link pending
twnd-20220930_pre.xml Edgar Link unprocessable
twnd-20220930_def.xml Edgar Link unprocessable
twnd-20220930_cal.xml Edgar Link unprocessable
twnd-20220930x10q_htm.xml Edgar Link completed
twnd-20220930_lab.xml Edgar Link unprocessable